Analyst firms · Leerink Partners · TSVT

Leerink Partners TSVT price target and rating history

2seventy bio Inc. (TSVT) · Health Care

Leerink Partners rates 2seventy bio Inc. (TSVT) Outperform with a $18 price target, as of its latest action on Jan 31, 2024. It has published 3 rating actions on TSVT since February 2022, including 1 upgrade and 1 downgrade.

Current rating
Outperform
Price target
$18
Median target, all firms
Too few
Actions on TSVT
3

Leerink Partners price target on TSVT

$38$22$62023202420252026
Leerink Partners price target on TSVT, each point a stated target, February 2022 to January 2024.

Every Leerink Partners rating on TSVT

Questions about Leerink Partners and TSVT

What is Leerink Partners's price target for TSVT?
Leerink Partners's latest stated price target for 2seventy bio Inc. (TSVT) is $18, from its action on Jan 31, 2024.
What is Leerink Partners's rating on TSVT?
Leerink Partners rates TSVT Outperform, a bullish rating, as of Jan 31, 2024.
When did Leerink Partners last change its view on TSVT?
On Jan 31, 2024, Leerink Partners upgrades to Outperform from Market Perform, price target $5 to $18.

More TSVT rating histories

All Leerink Partners ratingsTSVT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.